LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.85 | 17.25 | 440 | 5861 | 0.0751 | 0.4699 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.85 | 17.25 | 1 | 5861 | 0.0002 | -0.2873 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.85 | 17.25 | 704 | 5861 | 0.1201 | 0.5544 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.82 | 17.25 | 1 | 5924 | 0.0002 | -0.2869 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.82 | 17.25 | 389 | 5924 | 0.0657 | 0.4475 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.82 | 17.25 | 1 | 5924 | 0.0002 | -0.2869 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.82 | 17.25 | 657 | 5924 | 0.1109 | 0.5405 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.79 | 17.25 | 350 | 6008 | 0.0583 | 0.4283 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.79 | 17.25 | 643 | 6008 | 0.1070 | 0.5349 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.76 | 17.25 | 284 | 6047 | 0.0470 | 0.3928 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.76 | 17.25 | 611 | 6047 | 0.1010 | 0.5250 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.74 | 17.25 | 179 | 6109 | 0.0293 | 0.3182 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.74 | 17.25 | 614 | 6109 | 0.1005 | 0.5247 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.71 | 17.25 | 199 | 6184 | 0.0322 | 0.3340 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.71 | 17.25 | 480 | 6184 | 0.0776 | 0.4799 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 94.68 | 17.25 | 141 | 6239 | 0.0226 | 0.2804 | MN20160310_N02 | F05 |